News

New Tucson company aims to put life-saving devices in neighborhoods

CardioSpark is a way to “make neighborhoods cardiac safe,” said one of the company’s founders, Tucson cardiologist and mechanical engineer Carter Newton, who is working with many others including co-founder Nick Soloway, a Tucson attorney and entrepreneur.

Two prolific UA inventors win national honors

Dr. Marvin J. Slepian of the UA colleges of Medicine and Engineering and James Wyant, founding dean and professor emeritus of the College of Optical Sciences, will be inducted on April 15 during the annual conference of the National Academy of Inventors at the U.S. Patent and Trademark Office in Alexandria, Virginia.

Marvin J. Slepian, MD, to Be Honored with the AZBio Pioneer Award for Lifetime Achievement at the 2017 AZBio Awards

UA Researchers Go the Distance, Help Develop and Test Device for Body Chemistry and Fluid Analysis Via Sweat

A little larger than a quarter and about the same thickness, the simple, low-cost device helps the wearer quickly decide if any adjustments, such as drinking more water or replenishing salts, electrolytes and sugar, need to be made or if something is medically awry.  Designed for one-time use of a few hours, this device can be adapted and used for disease diagnosis and therapeutic monitoring. Details  were published Nov. 23 by the journal Science Translational Medicine.

CardioSpark, Slepian, ACABI team up to save lives

CardioSpark is a way to “make neighborhoods cardiac safe,” said one of the company’s founders, Tucson cardiologist and mechanical engineer Carter Newton, who is working with Dr. Marvin Slepian, of the Arizona Center for Accelerated Biomedical Innovation, and Dr. Karl Kern, a cardiologist and professor at the University of Arizona and chair of the Sarver Heart Center Resuscitation Research Group.  

UA Innovation Hub Headed by Slepian to Accelerate Translational Medical Research

The University of Arizona has announced the creation of a center focused on accelerating the development and commercialization of translational biomedical technologies.